Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAAR1 | Q96RJ0 | 10/20 | 0.53 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | LMNA | P02545 | 1/20 | 0.49 |
| ▸ | GLA | P06280 | 1/20 | 0.49 |
| ▸ | BLM | P54132 | 1/20 | 0.49 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.49 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.48 |
| ▸ | TERT | O14746 | 1/20 | 0.44 |
| ▸ | FDPS | P14324 | 1/20 | 0.41 |
| ▸ | TBXAS1 | P24557 | 2/20 | 0.40 |
| ▸ | HTR1A | P08908 | 1/20 | 0.40 |
| ▸ | CXCR4 | P61073 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15948859 | 0.93 | TAAR1 (0.52) | TAAR1CYP2D6TSHRLMNAGLA | |
| SCHEMBL11936762 | 0.87 | TAAR1 (0.57) | TAAR1CYP2D6TSHRLMNAGLA | |
| SCHEMBL27938415 | 0.87 | TAAR1 (0.57) | TAAR1CYP2D6TSHRLMNAGLA | |
| SCHEMBL8820632 | 0.87 | TAAR1 (0.47) | TAAR1CYP2D6TSHRLMNAGLA | |
| SCHEMBL1974427 | 0.85 | TAAR1 (0.46) | TAAR1CYP2D6TSHRLMNAGLA | |
| SCHEMBL1331599 | 0.83 | TAAR1 (0.54) | TAAR1CYP2D6TSHRLMNAGLA | |
| SCHEMBL825460 | 0.82 | TAAR1 (0.51) | TAAR1CYP2D6TSHRLMNAGLA | |
| SCHEMBL16243873 | 0.82 | TAAR1 (0.44) | TAAR1CYP2D6TSHRLMNAGLA | |
| SCHEMBL8151868 | 0.82 | TAAR1 (0.44) | TAAR1CYP2D6TSHRLMNAGLA | |
| SCHEMBL3106216 | 0.82 | CYP2D6 (0.49) | TAAR1CYP2D6TSHRLMNAGLA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-1996040170-A2 | METAL-CONTAINING COMPOUNDS AND THEIR USE FOR INHIBITING THE IMMUNE RESPONSE | PROCEPT, INC. (US) | 1996-12-19 | — | — | WO | claimed |
| US-20120016147-A1 | METHOD FOR PRODUCING AROMATIC COMPOUND POLYMER | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2012-01-19 | — | — | US | disclosed |
| US-8048982-B2 | Method for producing aromatic compound polymer | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2011-11-01 | — | — | US | disclosed |
| EP-2241548-A1 | Vanadium di-nuclear complex | Sumitomo Chemical Company, Limited (JP) | 2010-10-20 | — | — | EP | disclosed |
| EP-2241547-A1 | Method for producing aromatic compound polymer | Sumitomo Chemical Company, Limited (JP) | 2010-10-20 | — | — | EP | disclosed |
| US-20090018309-A1 | Method for Producing Aromatic Compound Polymer | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2009-01-15 | — | — | US | disclosed |
| US-7291692-B2 | Polyarylene oxide and method of producing the same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2007-11-06 | — | — | US | disclosed |
| EP-1767560-A1 | METHOD FOR PRODUCING AROMATIC COMPOUND POLYMER | Sumitomo Chemical Company, Limited (JP) | 2007-03-28 | — | — | EP | disclosed |
| US-7161000-B2 | Method for producing phenol condensate | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2007-01-09 | — | — | US | disclosed |
| US-20050096452-A1 | Polyarylene oxide and method of producing the same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2005-05-05 | — | — | US | disclosed |
| US-20040267057-A1 | Method for producing phenol condensate | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2004-12-30 | — | — | US | disclosed |
| US-6344516-B1 | TRANSITION METAL COMPLEX CATALYST, OXIDATATIVE POLYMERIZATION OF PHENOL-CONTAINING VEGETABLE OIL | NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) | 2002-02-05 | — | — | US | disclosed |
| EP-1114836-A1 | RESIN COMPOSITION AND PROCESS FOR PRODUCING THE SAME | Japan as represented by Secretary of Agency of Industrial Science and Technology (JP) | 2001-07-11 | — | — | EP | disclosed |
| WO-1996040170-A2 | METAL-CONTAINING COMPOUNDS AND THEIR USE FOR INHIBITING THE IMMUNE RESPONSE | PROCEPT, INC. (US) | 1996-12-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090018309-A1 | Method for Producing Aromatic Compound Polymer | PAH, MAOA, AHR | TAAR1 2691/4885CYP2D6 870/4885TSHR 3657/4885 |
| US-20040267057-A1 | Method for producing phenol condensate | SOD1, MLX, XDH | TAAR1 4316/4885CYP2D6 2513/4885TSHR 3660/4885 |
| US-20120016147-A1 | METHOD FOR PRODUCING AROMATIC COMPOUND POLYMER | PAH, MAOA, AHR | TAAR1 2764/4885CYP2D6 813/4885TSHR 3727/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.